CHUL
2705, boulevard Laurier
R-00-771
Québec, Québec
Canada G1V 4G2

Dernières nouvelles

Information non disponible

141 enregistrements « 1 de 15 »

Goldstein I, Bélanger A, Cusan L, Archer D, Nappi RE, Portman D, Gudeman J

In Memoriam: Fernand Labrie, June 28, 1937 – January 16, 2019

Article de revue

Sex Med Rev, 7 (2), 2019.

| Liens:

Bouchard C, Labrie F, Derogatis L, Girard G, Ayotte N, Gallagher J, Cusan L, Archer DF, Portman D, Lavoie L, Beauregard A, Cote I, Martel C, Vaillancourt M, Balser J, Moyneur E,

Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study

Article de revue

Horm Mol Biol Clin Investig, 25 (3), 2016.

Résumé | Liens:

Labrie F, Archer DF, Koltun W, Vachon A, Young D, Frenette L, Portman D, Montesino M, Cote I, Parent J, Lavoie L, Beauregard A, Martel C, Vaillancourt M, Balser J, Moyneur E,

Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause

Article de revue

Menopause, 23 (3), 2016.

Résumé | Liens:

Labrie F, Derogatis L, Archer DF, Koltun W, Vachon A, Young D, Frenette L, Portman D, Montesino M, Cote I, Parent J, Lavoie L, Beauregard A, Martel C, Vaillancourt M, Balser J, Moyneur E,

Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy

Article de revue

J Sex Med, 12 (12), 2015.

Résumé | Liens:

Archer DF, Labrie F, Bouchard C, Portman DJ, Koltun W, Cusan L, Labrie C, Cote I, Lavoie L, Martel C, Balser J,

Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone)

Article de revue

Menopause, 22 (9), 2015.

Résumé | Liens:

Portman DJ, Labrie F, Archer DF, Bouchard C, Cusan L, Girard G, Ayotte N, Koltun W, Blouin F, Young D, Wade A, Martel C, Dube R,

Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal women

Article de revue

Menopause, 22 (12), 2015.

Résumé | Liens:

Labrie F, Archer DF, Bouchard C, Girard G, Ayotte N, Gallagher JC, Cusan L, Baron M, Blouin F, Waldbaum AS, Koltun W, Portman DJ, Cote I, Lavoie L, Beauregard A, Labrie C, Martel C, Balser J, Moyneur E,

Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study

Article de revue

Maturitas, 81 (1), 2015.

Résumé | Liens:

Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dube R, Cote I, Labrie C, Lavoie L, Gilbert L, Martel C, Balser J

Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women

Article de revue

J Sex Med, 11 (7), 2014.

Résumé | Liens:

Labrie F, Martel C, Berube R, Cote I, Labrie C, Cusan L, Gomez JL

Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens

Article de revue

J Steroid Biochem Mol Biol, 138 , 2013.

Résumé | Liens:

Labrie F, Archer DF, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dube R, Cote I, Labrie C, Lavoie L, Berger L, Gilbert L, Martel C, Balser J

Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia

Article de revue

Climacteric, 14 (2), 2011.

Résumé | Liens:

141 enregistrements « 1 de 15 »
Signaler des ajouts ou des modifications